Business Leaders

Dr. Scott Rocklage a Full Life in Pharmaceuticals

**UPDATE 7/17/17**
Scott Rocklage is not a leader to miss, so check him out. He is a healthcare manager and more. He is also a known biopharmaceutical expert.

Primary Role
Managing Partner for 5AM Ventures

8 Investments throughout 4 Companies

Menlo Park


Social Media:
Primarily Facebook and Twitter

Title Company
Executive Chairman EntreMed
Chairman and CEO Cubist Pharmaceuticals
R&D positions Catalytica
Executive Chairman Ilypsa
Executive Chairman Relypsa
President and CEO Nycomed Salutar


University of California
B.S. in Chemistry

Massachusetts Institute of Technology – or MIT
Ph.D. in Chemistry

Date of Publication and Release
April 2017 – Scott Rocklage – Managing Partner for 5AM Ventures
March 2016 PE HUB – Aprea AB has raised $51 million
March 2013 Fin SMEs – Novira Therapeutics Secured $7.5M; Completed A Financing
August 2012 Fin SMEs – Novira Therapeutics Secured $23M in Series A Financing

Rocklage’s Board & Advisor Roles

Board Member

VBI Vaccines
Board Member

Novira Therapeutics
Board of Directors

Board of Directors

Board Chairman

Board of Directors

Epirus Biopharmaceuticals
Board of Director

Whitehead Institute for Biomedical Research
Board of Associates

Board Chairman

As if these traits alone were not more than enough to show commitment, courage, honor, sacrifice, intelligence, innovation and inspiration, there’s more. Check it out. Rocklage has also invested many times.

Semprus BioSciences
Board Chairman

Current Investments Held
Date Investment Made Round Other Details
March of 2013 Novira $25M / Series A (Lead) 5AM Ventures
March of 2013 Achaogen $18.91M / Series D 5AM Ventures
August of 2011 Pulmatrix $14M / Series B 5AM Ventures
April of 2010 Achaogen $56M / Series C 5AM Ventures
November of 2009 Pulmatrix $30.2M / Series 5AM Ventures
March of 2009 Pulmatrix $3.5M / Series A 5AM Ventures
March of 2009 Rennovia $16.33M / Series A 5AM Ventures
October of 2006 Achaogen $26M / Series B 5AM Ventures

In the field of health care, Scott Rocklage has 20 years’ experience and credibility. He has been involved in the approval of three applications made by FDA for new drugs and has entered six drug candidates into clinical trials. He became the Managing Partner of 5M Ventures in 2004, but it was in 2003 that saw him join the company. He has served in other companies such as Cubist Pharmaceuticals where he held the chairmanship position, in Nycomed Interventional as CEO and Chairman and in Salutar and Catalytica he was in R&D. Positions he is still maintaining is the chair of the board at Achaogen, Relypsa, and Semprus.

Rocklage received his B.S. in the field of chemistry from California University, Berkeley and got his Ph.D. from Massachusetts Institute of Technology where he had specialized in chemistry. He got the best support while undertaking his Ph.D. as his supervisor was the Noble Prize winner in Chemistry, Professor Richard R. Schrock.

Scott contributes to different organizations and political agendas. His first contribution to the Federal Political contribution was in 2002 for $ 500 and the most recent contribution being a $500 made in 2012, but in total his contributions amount to $ 3,900.
Scott Rocklage understands well the need to give back to the community and recently together with his wife contributed $ 250,000 to help with the renovation of nanochemistry and nanotechnology lab space. He worked hard to gain acceptance in the then-nascent Richard R. Schrock research group and was able to be part of a fun, dedicated group. There was a lot of competition in MIT for projects, glove-box time thus created quite the volatile atmosphere. Thus the best performance was brought out by each student and Scott is still making strides in his career using the same spirit. His contribution to the department was no struggle as he knew MIT gave him a solid foundation for his professional life and career and he was just saying thank in a loud way.

Making partner in 5M Venture is a great achievement, 5M Ventures is a company specializing in startup companies. Its focus is mostly the media for equity, in that it buys a stake in companies as a way to grow capital transactions with a hope of getting space for advertisement. The company headquarters is Paris France and focuses on investing in businesses to customer sector companies. This is a company with a team of professionals as well as investors that have a passion for building a market leader. The company invests in the education sector, the internet and mobile sector to deal with any difficulties a customer faces. Talk of professionals and you will understand why Scott Rocklage made partner.

Leave a Reply

Your email address will not be published. Required fields are marked *